Insights

    AdvisoryDx
    Intelligence

    Perspectives on adoption architecture, market access, and reimbursement strategy

    Strategic Briefing

    The Adoption Paradox: Why Diagnostic Innovation Is Accelerating while Clinical Integration Is Slowing.

    An analysis of the widening chasm between FDA clearance and sustainable clinical revenue. We explore the structural failures in traditional launch sequencing and the architectural shifts required to turn scientific validation into repeatable adoption.

    By Scott Robitaille  |  6 Min Read

    Read Strategic Briefing

    Curated Resources

    Market Access Architecture: A Blueprint for Repeatable Clinical Adoption

    A structured methodology for turning scientific validation into scalable clinical revenue.

    Read More

    The Investor's Diagnostic Diligence: 10 Critical Questions for Commercial Viability

    A strategic tool for evaluating commercial infrastructure and de-risking post-clearance adoption.

    Download PDF

    Next Step

    Navigating the commercialization window

    Most diagnostic companies are not designed for adoption at scale.

    AdvisoryDx works with founders and investors to design and install the commercial architecture required for repeatable adoption.